Showing recent highlights
What's New
PubMed · December 31, 2026
Researchers looked at a group of studies and found that low sodium levels in the blood — a condition called hyponatremia, where the body doesn't have enough of this important mineral — appear to be surprisingly common in people with COPD (a serious lung disease that makes breathing difficult). About 1 in 5 people with a sudden COPD flare-up may have this issue, which is worth paying attention to because low sodium can affect how the body functions overall. Interestingly, most of the studies didn't find a clear link between low sodium and a higher risk of death from a COPD flare-up, but scientists say the results varied too much between studies to draw firm conclusions. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers in China tested whether a low dose of an older medicine called theophylline — which can reduce inflammation in the airways — might help people with mild to moderate COPD, a lung disease that makes breathing harder over time. They found a small improvement in lung function (how much air people could blow out), but the medicine did not reduce the number of times patients had flare-ups, which are sudden worsening spells that can be dangerous. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
A study found that in ex-smokers — both those with COPD and those considered at risk for it — mucus plugs in the airways kept forming and shifting over time, even when overall mucus levels stayed roughly the same. More importantly, these participants also showed a gradual decline in how far they could walk and how well air moved through their lungs, suggesting that mucus buildup may be quietly contributing to worsening lung health even in earlier or milder stages of the disease. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that people with COPD — a lung condition that makes it hard to breathe — face a mix of real-world challenges when trying to manage their condition day to day. Things like rushed doctor appointments, feelings of shame or emotional distress, and not getting enough clear information from healthcare professionals made it harder for people to stick to their treatment plans, while having strong support from family and friends and feeling genuinely heard by their care team made a big difference. Understanding what gets in the way — and what helps — could lead to better, more personalized support for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that certain biologic medications — injectable drugs that target specific parts of the immune system to reduce inflammation — may help people with moderate-to-severe COPD (a serious lung disease that makes breathing difficult) have fewer flare-ups, which are episodes when symptoms suddenly get much worse. Specifically, they found that for every 12 to 17 people treated with a biologic called dupilumab, roughly one person avoided a flare-up they otherwise would have had — and when looking at the total number of flare-ups prevented, the benefit appeared even stronger. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · December 1, 2026
Researchers found that digital tools designed to help people with COPD (a lung disease that makes breathing difficult) manage their condition on their own — things like apps, online programs, or remote monitoring — were linked to improvements in physical activity, quality of life, lung function, medication adherence, and mental health challenges like anxiety and depression. This matters because COPD can be isolating and hard to manage day-to-day, and digital tools could make support more accessible to more people. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 24, 2026
Researchers found that very few people with COPD — a lung disease that makes breathing difficult — ever take part in pulmonary rehabilitation, which is a structured program of exercise and education designed to help them breathe better and stay active, and even fewer finish it. To help bridge that gap, a study is testing whether a smartphone app can help people with COPD stay motivated and keep moving on their own after their in-person program ends. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 17, 2026
Researchers found that people with COPD (a lung disease that makes breathing difficult) face a mix of personal and social challenges that affect how active they stay in daily life — things like managing symptoms and low mood, but also what helps them keep moving, such as support from family, friends, and healthcare providers. Even after completing breathing rehabilitation programs, many people tend to slip back into sitting still most of the day, and this review looked at why that happens and what makes a difference. Understanding these real-life experiences could help create better, more personal support plans for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
Watch Out For
FDA MedWatch · July 15, 2026
Be aware that certain ResMed Astral breathing machines (ventilators) may have a faulty electrical part that could cause the device to stop working unexpectedly, which could be very dangerous or even life-threatening for people who depend on it to breathe. If someone uses one of these machines, they or their caregiver should watch for any signs that the device is not working as expected, such as unusual alarms, the machine shutting off, or the person having trouble breathing. Anyone using this device should contact their doctor or equipment provider right away to find out if their specific machine is affected.
Ask your doctor: Ask the doctor whether the patient's Resmed Astral ventilator is one of the models with the electrical component problem that was recently reported, and what the patient should do about it.
Watch Out For
FDA MedWatch · July 14, 2026
Be aware that certain Volera breathing devices (made by Baxter) may have a problem where air and medication leak out during use, which could mean patients aren't getting enough oxygen or their full dose of inhaled medication. People using this device should watch for any signs that their breathing treatment doesn't seem to be working as well as usual, or if they feel short of breath or unwell during or after a session. Anyone with concerns about their device or how they're feeling during treatment should reach out to their doctor or care team right away.
Ask your doctor: Ask the doctor whether the patient's Volara positive pressure breathing device has been checked for air leaks that could reduce how much oxygen the patient is getting during treatment.
What's New
PubMed · July 14, 2026
Researchers found that a group of newer injectable medications — called biologics — can help certain people with COPD (a lung disease that makes breathing harder over time) who have a specific type of airway inflammation in their lungs. In those patients, these medications reduced flare-ups — called exacerbations, meaning episodes when breathing suddenly gets much worse — by about 23%, and also slightly improved lung function and quality of life. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 13, 2026
Researchers found that a breathing support machine set to adjust automatically overnight worked about as well as one carefully tuned by a sleep specialist when it came to helping people with a serious lung condition called COPD breathe better at night and keep carbon dioxide levels in their blood at a healthier level. However, the automatic setting used higher air pressure and felt less comfortable to patients than the manually adjusted setting — a difference that could matter for people who already find it hard to tolerate wearing a breathing mask while they sleep. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 13, 2026
Researchers found that self-management programs designed to be easier to understand — for example, using simpler language, pictures, or hands-on coaching — helped people with COPD (a lung disease that makes breathing difficult) breathe better, walk farther, and feel better overall compared to those who received standard care alone. The idea is that when health information is presented in a way that's easier to grasp, people are better able to manage their condition day to day. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 8, 2026
Researchers are studying whether a structured, primary-care-based program in China — where doctors follow up with COPD patients every three months and provide education and guided disease management — can reduce the number of times patients suddenly get much worse (called flare-ups) and improve their overall quality of life. COPD, or chronic obstructive pulmonary disease, is a long-term lung condition that makes breathing progressively harder, and it affects a very large number of people in China who currently aren't getting consistent, guideline-based care. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · July 1, 2026
This study looked at people with severe COPD (a lung disease that makes breathing very difficult) and found that simply directing a small handheld fan toward the face for 15 minutes every day made a real difference over six weeks — people reported less breathlessness, less anxiety, and less depression compared to those who didn't use a fan. The idea is that cool airflow across the face seems to ease the uncomfortable sensation of struggling to breathe, which in turn helps people feel calmer and less distressed. This is something a person could try today with any inexpensive handheld fan, though it's always worth talking with your doctor about how it might fit into their overall care.
What's New
PubMed · July 1, 2026
Researchers found that using a breathing support mask (called non-invasive ventilation) in the ambulance — before reaching the hospital — may help people with COPD recover more quickly during a severe flare-up, compared to standard treatment alone. COPD, or chronic obstructive pulmonary disease, is a lung condition that makes it hard to breathe, and during a bad flare-up, some people's blood can become dangerously acidic because they can't breathe out enough; the study suggested that starting the breathing mask early helped correct this faster. However, the study was stopped early and only included 14 people, which is a very small number, so the results are hard to rely on — this is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that pulmonary rehabilitation — a structured program of exercise and education designed to help people with COPD breathe better and stay active — has been studied in many different ways, making it hard to compare results across studies. In a review of 95 studies involving over 200,000 people, researchers noticed that important concerns for older adults, like balance, frailty, and physical activity, were rarely measured, even though these things greatly affect quality of life as people age. This gap matters because without consistent tracking of these outcomes, doctors may not have a full picture of how well rehabilitation is working for older patients with COPD. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed · July 1, 2026
According to the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Palliative Care (SECPAL) guidelines, people with advanced COPD — a serious lung disease that makes breathing increasingly difficult — should be offered palliative care (comfort-focused support) earlier in their illness, based on how much they're struggling day to day, not just on how long they're expected to live. These guidelines recommend a team-based approach that brings together lung specialists, palliative care providers, and others to tackle breathing symptoms, emotional wellbeing, and support for family caregivers all at once. The goal is to help people live as comfortably as possible and reduce unnecessary suffering.
What's New
PubMed · June 24, 2026
Researchers found that tiny plastic particles floating in the air — called microplastics and nanoplastics — may be harmful to the lungs, and people with COPD could be especially vulnerable. The smallest particles can travel deep into the lungs, triggering inflammation (the body's irritation response) and damage, while larger plastic particles act as ongoing irritants in the airways — both of which can make COPD flare-ups more frequent and lung function worse over time. People who live in cities or work in certain industries appear to face higher exposure to these particles. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 18, 2026
Researchers found that people with COPD who also have a mental health condition — such as depression or anxiety — tend to have worse outcomes across the board, including poorer lung function, more difficulty walking, worse quality of life, and a higher chance of being hospitalized or having a serious flare-up of their COPD symptoms. Looking at data from over 700,000 people across 58 studies, the connection was consistent and meaningful, suggesting that mental and physical health are deeply linked for people living with COPD. This is early research and hasn't yet changed treatment guidelines.
Watch Out For
FDA MedWatch · June 11, 2026
Be aware that certain Volara breathing therapy devices may have a problem where air and medicine can leak out during use, which means patients might not be getting enough oxygen or the right amount of their inhaled medication. If someone using this device notices it doesn't seem to be working as expected, feels short of breath, or feels their treatment isn't helping the way it usually does, it's important to let their doctor or care team know right away.
Ask your doctor: Ask the doctor whether the patient uses a Volara system for breathing treatments and if so, whether the patient should be checked for any air or medication leaks during nebulizer therapy.
What's New
PubMed · June 4, 2026
Researchers found that using three inhaled medications together for COPD (a condition where the airways are blocked and breathing is difficult) didn't consistently work better than using just two medications to prevent flare-ups, which are episodes when symptoms suddenly get much worse. Some two-drug combinations actually ranked among the best options for preventing those flare-ups, suggesting more medication isn't always better. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · June 1, 2026
This research looked at older people who have both COPD and sarcopenia (significant muscle loss that comes with aging) and tested whether combining aerobic exercise — like walking or cycling — with resistance exercise — like lifting light weights or using resistance bands — worked better than doing just one type alone. The combined approach showed meaningful improvements in how much air people could breathe in and out, as well as in breathing muscle strength, while aerobic exercise alone did not produce the same gains. Someone with these conditions could, in principle, start today by pairing a 20–30 minute walk with a short session of light strength moves (such as seated leg lifts or gentle resistance-band pulls), though talking with your doctor first is important to make sure any exercise plan fits your personal health situation.
Lifestyle
PubMed · June 1, 2026
A study found that people with COPD (a lung disease that makes breathing difficult) who took part in a 10-week program called 'Active for Life' walked significantly more steps each day — about 1,200 more steps per day right after the program ended — compared to people in a basic chair exercise group. Researchers found these gains lasted up to a year, with participants still walking around 400 extra steps per day at the 12-month mark. The program focused on light, manageable movement rather than intense exercise, making it easier for people with COPD to stick with over time.
What's New
PubMed · June 1, 2026
Researchers found that a three-week breathing and exercise program — called pulmonary rehabilitation — helped people with COPD breathe more easily, walk farther, and feel better overall, regardless of whether they did one or two sessions per day. Interestingly, doing twice as many sessions each day didn't produce noticeably better results than the standard once-a-day approach, which could be encouraging news for people who find intensive schedules hard to keep up with due to cost or other health issues. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
PubMed · May 27, 2026
Researchers found that people living with COPD — a lung condition that makes breathing difficult — want practical, hands-on guidance for managing their day-to-day lives, such as knowing how to pace their breathing during simple activities like walking or climbing stairs, when to use their inhalers, and how to recognize when symptoms are getting worse. The study found that people felt more confident and in control of their condition when they understood these specific steps and had support to practice them regularly. Researchers also found that people with COPD expressed a strong need for emotional support alongside physical guidance, because the condition can affect mood and independence as much as it affects breathing.
What's New
PubMed · May 23, 2026
Researchers found that a drug called astegolimab, given by injection every two or four weeks, was studied in people with COPD (a lung disease that makes breathing difficult) who had frequent flare-ups — periods when symptoms suddenly get much worse. The trials looked at whether astegolimab could reduce how often those flare-ups happened, which matters because frequent flare-ups can lead to hospital stays and faster decline in lung health. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · May 22, 2026
Researchers found that spending time in underground salt caves — a therapy called speleotherapy — may help people with asthma breathe better and feel more in control of their symptoms. Over three weeks, people with asthma who did six two-hour underground sessions reported improvements in how well they could manage their asthma day-to-day, compared to those who only continued their usual treatment. This is early research and hasn't yet changed treatment guidelines.
Watch Out For
FDA MedWatch · May 21, 2026
Be aware that React Health has recalled certain VOCSN V+Pro ventilators — breathing support machines — because a manufacturing problem may cause oxygen to leak in a way that the device doesn't detect or warn about. An undetected oxygen leak could affect how well the machine delivers the right amount of air to the person using it. Anyone using one of these devices should contact their doctor or care team right away to find out if their specific machine is affected.
Ask your doctor: Ask the doctor whether the patient is using a VOCSN V+Pro ventilator and whether the patient should be concerned about the recent recall of these devices due to potential oxygen leaks.
Medications
PubMed · May 20, 2026
Researchers found that statins — cholesterol-lowering medications like Lipitor or Crestor — may help reduce serious flare-ups and related hospital visits in people with COPD, a lung disease that makes breathing difficult. Across three studies involving about 1,190 patients, those taking statins had fewer severe flare-ups compared to those taking a placebo (a dummy pill with no active ingredients), though the researchers noted the overall quality of the evidence was low. This appears to be an emerging area of interest rather than an established treatment, and the findings suggest statins could be worth further investigation for people with COPD.
Ask your doctor: Ask the doctor whether taking a statin drug like atorvastatin might help reduce how often the patient has flare-ups or exacerbations from COPD.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.